Age verification
Ipamorelin / CJC-1295 Blend supplied as a lyophilised 10 mg vial. Tested at 99.200% purity by an independent laboratory. Certificate published under lot 2648431644.
99+
Every lot goes to an independent laboratory for HPLC purity and LC-MS identity before release.
24h
Orders placed before 2 PM Pacific leave the warehouse the same working day, tracked end to end.
COA
Read the certificate for the exact lot you will receive before you place the order, not after.
Certificate of analysis
The certificate here belongs to the vial you are ordering, not to a representative batch. Purity by HPLC, identity by LC-MS and endotoxin screening, run by an independent laboratory.
Lyophilised powder is stable at ambient temperature in transit. On arrival, store sealed vials in a cool, dry, dark place. For storage beyond three months, keep at −20 °C.
Add bacteriostatic water slowly down the inner vial wall. Do not shake — swirl gently until fully dissolved.
Refrigerate at 2–8 °C and protect from light. Use within 30 days. Discard if the solution becomes cloudy or discoloured.
For laboratory research use only. Not for human or veterinary consumption. Not a drug or dietary supplement.
Research record · preclinical
The Ipamorelin / CJC-1295 Blend is a pre-mixed research formulation of two synthetic peptides: Ipamorelin: A pentapeptide growth hormone secretagogue reported to act through a GHRP-like receptor rather than the GHRH receptor, and CJC-1295 (No DAC): A GHRH analog studied for its interaction with the GHRH receptor and its role in pulsatile growth hormone signaling. Each 10 mg vial holds 5 mg of each peptide. Because the two are described as acting at separate receptors, the pair is examined together in experimental models rather than as single agents. Pure Forge Labs supplies high-purity, third-party verified Ipamorelin + CJC-1295 No DAC blend designed to ensure reliable and repeatable research results. Sold for research use only.
01
The original characterisation describes a pentapeptide identified within a series of compounds lacking the central Ala-Trp dipeptide of GHRP-1. In primary rat pituitary cells it released growth hormone with potency and efficacy reported as similar to GHRP-6, at an EC50 of 1.3 nmol/l against 2.2 nmol/l. Profiling with GHRP and GHRH antagonists indicated that release proceeds through a GHRP-like receptor and not through the GHRH receptor.
02
The published human pharmacology of CJC-1295 concerns the form carrying a drug affinity complex, a maleimido group that binds covalently to plasma proteins such as serum albumin and gives conjugates a far longer half-life. Two randomised placebo-controlled trials of that form described dose-dependent increases in mean plasma growth hormone of two- to ten-fold sustained for six days or more. The certificate for this vial names CJC-1295 no DAC, the form without that complex, and anti-doping work treats the two as separate analytes.
03
The basis for pairing these two is that they are described as reaching the same axis by different doors: a GHRH analogue at the GHRH receptor, and a secretagogue at the GHRP-like receptor that the antagonist work distinguishes from it. A 2026 narrative review of injectable peptide therapy assessed CJC-1295 with ipamorelin as one of the entries in its scope, which records the combination as one that is marketed and used rather than one that has been trialled.
| Research area | Assay |
|---|---|
| Receptor pharmacology | Antagonist profiling against GHRP and GHRH receptor blockade |
| Pituitary cell culture | Growth hormone release from primary rat somatotropes |
| Human pharmacology | Plasma growth hormone and IGF-I after subcutaneous dosing |
| Analyte identity | In vitro metabolism of GHRH analogues in fortified urine |
| Detection methods | LC-MS/MS after immunoaffinity capture and tryptic digestion |
The record is on the two peptides separately. A 2026 review lists CJC-1295 with ipamorelin among the peptide therapies marketed direct to patients, which documents that the pairing is sold and used, not that the pairing has been tested. Two limits carry over from the components and neither is small. The human dose-ranging trials were run on the drug affinity complex form that binds albumin, while the certificate for this vial names CJC-1295 no DAC, so the multi-day durations reported in those trials do not describe what is in it. The ipamorelin characterisation is preclinical, in rat pituitary cells and two animal species, and dates to 1998. Administration of GHRH analogues is prohibited by the World Anti-Doping Agency, and neither compound holds FDA approval.
No notes yet — be the first to write one.
Ordering, handling and compliance. Anything not covered here, write to support@pureforgelabs.com.
Every compound we sell is supplied for laboratory research and development only. It is not a drug, not a supplement, and not intended to diagnose, treat, cure or prevent any condition in humans or animals. Buying from this site means you are acquiring it for in vitro or other controlled research work.
Purchasers must be 21 or older and are responsible for compliance with the law where they take delivery. We ship to research institutions, laboratories and qualified individual researchers. We do not ship to jurisdictions where these compounds are restricted.
Check three things in order. First, the lot code on the certificate matches the code printed on your vial. Second, the HPLC chromatogram shows a single dominant peak with the stated purity figure. Third, the LC-MS mass matches the expected molecular weight, here 1419.56 g/mol. Anything that does not line up, send us the lot code.
Add bacteriostatic water slowly down the inner wall of the vial and swirl — never shake. Once in solution, refrigerate at 2–8 °C, protect from light and use within 30 days. Unopened vials keep at ambient temperature short term, or at −20 °C beyond three months.
Orders placed before 2 PM Pacific dispatch the same working day. Domestic delivery is two days, with tracking sent on dispatch. Shipping is free on orders over $200. International orders go out with a commercial invoice; transit is typically five to nine days.
Institutional purchase orders and bank transfer are available on wholesale accounts — apply through the wholesale programme and we will set up terms.
Photograph the vial and outer packaging and email us within 48 hours of delivery. We replace damaged or compromised vials at our cost. Unopened vials can be returned within 30 days; opened vials cannot be resold and are not returnable.
Yes. Volume pricing on this page runs to five vials; beyond that, a wholesale account gives tiered pricing, reserved lots and consolidated shipping. Reserved lots matter for multi-month studies where you need the same batch throughout.
FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY CONSUMPTION. This product is intended solely for legitimate laboratory, analytical, and scientific research. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease and is not intended for human or veterinary administration or consumption. All products are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.
One short email when something changes. No drip campaigns.
Leave a researcher note